Definition of a novel breast tumor-specific classifier based on secretome analysis

Breast Cancer Research

Research

Lilith Faucheux¹  Maximilien Grandclaudon²  Alix Scholer-Dahirel²  Maude Guillot-Delost²  Paula Michea²  Philémon Sirven²  Vassili Soumelis³  Fatima Mechta-Grigoriou⁴  Anne Vincent-Salomon⁵ 

[1] INSERM U976, Université de Paris, IRSLHôpital Saint Louis, 75006, Paris, France;INSERM UMR1153, Université de Paris, ECSTRRA Team, 75006, Paris, France;INSERM Unit U932, Immunity and Cancer, Institut Curie, Paris, France;Paris Sciences Lettres (PSL) University, Paris, France;Center of Clinical Investigation, CIC IGR-Curie 1428, Paris, France;INSERM Unit U932, Immunity and Cancer, Institut Curie, Paris, France;Paris Sciences Lettres (PSL) University, Paris, France;Center of Clinical Investigation, CIC IGR-Curie 1428, Paris, France;INSERM U976, Université de Paris, IRSLHôpital Saint Louis, 75006, Paris, France;Department of Immunology-Histocompatibility, AP-HP, Hôpital Saint-Louis, 75010, Paris, France;Paris Sciences Lettres (PSL) University, Paris, France;Centre de Recherche, Stress and Cancer Laboratory, U830 Genetics and Biology of Cancers, INSERM, Institut Curie, Paris, France;Paris Sciences Lettres (PSL) University, Paris, France;Diagnostic and Theranostic Medicine Division, Institut Curie, Paris, France;

关键词: Breast cancer;    Secretome;    Tumor;    Juxta-tumor;    Breast tumor-specific signature;   

DOI  :  10.1186/s13058-022-01590-4

 received in 2022-10-03, accepted in 2022-12-07,  发布年份 2022

来源: Springer

【 授权许可】

CC BY   
© The Author(s) 2022

【 图 表 】

Fig. 3

Fig. 2

Fig. 1

Fig. 1

Fig. 1

Fig. 4

Fig. 6

Fig. 1